54878-01-2

Basic information

• Product Name: METHYL (1R,3S)-2,2-DIMETHYL-3-(2-OXOPROPYL)-CYCLOPROPANEACETATE, 96
• Synonyms: METHYL (1R,3S)-2,2-DIMETHYL-3-(2-OXOPROPYL)-CYCLOPROPANEACETATE, 96;METHYL (1 R,3 S)2-2 DIMETHYL -3-(OXOPROPYL)-CYCLOPROPANEACETATE
• CAS NO: 54878-01-2
• Molecular Formula: C₁₁H₁₈O₃
• Molecular Weight: 182.261
• Mol File: 54878-01-2.mol

Chemical Properties

• Boiling Point: 104-106°C/3mmHg
• Flash Point: 100.1°C
• Appearance: Clear brown/Liquid
• Density: 0.989g/cm³
• Vapor Pressure: 0.0265mmHg at 25°C
• Refractive Index: 1.44
• Storage Temp.: Refrigerator (+4°C)
• CAS DataBase Reference: METHYL (1R,3S)-2,2-DIMETHYL-3-(2-OXOPROPYL)-CYCLOPROPANEACETATE, 96(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL (1R,3S)-2,2-DIMETHYL-3-(2-OXOPROPYL)-CYCLOPROPANEACETATE, 96(54878-01-2)
• EPA Substance Registry System: METHYL (1R,3S)-2,2-DIMETHYL-3-(2-OXOPROPYL)-CYCLOPROPANEACETATE, 96(54878-01-2)

Safety Data

• Hazardous Substances Data: 54878-01-2(Hazardous Substances Data)

Usage

Chemical Properties

clear brown liquid

InChI:InChI=1/C11H18O3/c1-7(12)5-8-9(11(8,2)3)6-10(13)14-4/h8-9H,5-6H2,1-4H3/t8-,9+/m0/s1

Upstream product

• 186581-53-3 diazomethane 
• 498-15-7 (+)-Δ³-carene 
• 67-56-1 methanol 
• 936-02-7 2-Hydroxybenzoylhydrazine 

Downstream Products

• 530100-19-7 (+)-[(1R,3S)-2,2-dimethyl-3-(2-methyl-1H-indol-3-yl)cyclopropyl]acetic acid 
• 340165-10-8 (1R,5R)-6,6-dimethyl-2-(1-hydroxyethylidene)-bicyclo<3.1.0>hexan-3-one 
• 80408-87-3 (+)-5,5-dimethyl-4-(3-oxobutyl)tetrahydrofuran-2-one 
• 89722-18-9 methyl 2,4-dimethylphenyl acetate 
• 910811-37-9 1-(3-(2,6-dimethyl-4-(3-oxo-3-((3bS,4aR)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-c]thiophen-1-yl)propyl)phenoxy)propyl)azetidine-3-carboxylic acid 
• 910811-17-5 1-(3-(2,6-dimethyl-4-(3-oxo-3-((3bS,4aR)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-c]thiophen-1-yl)propyl)phenoxy)-2-hydroxypropyl)azetidine-3-carboxylic acid 
• 910811-16-4 2-((3-(2,6-dimethyl-4-(3-oxo-3-((3bS,4aR)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-c]thiophen-1-yl)propyl)phenoxy)-2-hydroxypropyl)amino)acetic acid 
• 910812-46-3 1-(3-(2,6-dimethyl-4-(3-oxo-3-((3bS,4aR)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-c]thiophen-1-yl)propyl)phenoxy)propyl)azetidine-3-carboxylic acid 
• 910811-11-9 2-((3-(2,6-dimethyl-4-(3-oxo-3-((3bS,4aR)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-c]thiophen-1-yl)propyl)phenoxy)propyl)amino)acetic acid 
• 910811-14-2 3-(4-(3-((2-hydroxyethyl)amino)propoxy)-3,5-dimethylphenyl)-1-((3bS,4aR)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-c]thiophen-1-yl)propan-1-one 
• 910811-10-8 3-(4-(3-((2-hydroxyethyl)amino)propoxy)-3,5-dimethylphenyl)-1-((3bS,4aR)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-c]thiophen-1-yl)propan-1-one 
• 910812-30-5 3-(3,5-dimethyl-4-(3-(methylamino)propoxy)phenyl)-1-((3bS,4aR)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-c]thiophen-1-yl)propan-1-one 
• 910812-29-2 3-(4-(3-aminopropoxy)-3,5-dimethylphenyl)-1-((3bS,4aR)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-c]thiophen-1-yl)propan-1-one 
• 910811-05-1 3-(4-(2-(dimethylamino)ethoxy)-3,5-dimethylphenyl)-1-((3bS,4aR)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-c]thiophen-1-yl)propan-1-one 

Relevant articles and documents

Synthesis of Isonicotinic and Salicylic Acids Derivatives from (–)-α-Pinene and (+)-Δ3-Carene

Abstract: Optically active cyclobutanediyl- and cyclopropanediylbisalkylidenedihydrazides of isonicotinic and salicylic acids were synthesized when theperoxide products of ozonolysis of (–)-α-pinene and(+)-Δ3-carene were reduced with isonicotin

MODIFIED OXIDATION OF (+)-3-CARENE BY POTASSIUM PERMANGANATE

The oxidation of (+)-3-carene under the conditions of phase-transfer catalysis has been studied.It has been shown that when the reaction is performed in acetic acid the keto acids (IIa) and (IIIa) and (-)-3α-hydroxycaran-4-one (IV) are formed.